1. Hecking T, Abramian A, Domröse C, Engeln T, Thiesler T,
Leutner C, Gembruch U, Keyver‑Paik MD, Kuhn W and Kübler K:
Individual management of cervical cancer in pregnancy. Arch
Gynecol Obstet 293: 931‑939, 2016.
2. de Haan J, Verheecke M, Van Calsteren K, Van Calster B,
Shmakov RG, Mhallem Gziri M, Halaska MJ, Fruscio R,
Lok CAR, Boere IA, et al: Oncological management and
obstetric and neonatal outcomes for women diagnosed with
cancer during pregnancy: A 20‑year international cohort study
of 1170 patients. Lancet Oncol 19: 337‑346, 2018.
3. World Health Organization/International Agency for Research
on Cancer. Cervix uteri. Source: Globocan 2018. Available from:
http://gco.iarc.fr/today/data/factsheets/cancers/23‑Cervix‑uteri‑f
act‑sheet.pdf. Accessed October 31, 2020.
4. Cancer Registry and Statistics. Cancer Information Service,
National Cancer Center, Japan (Monitoring of Cancer
Incidence in Japan (MCIJ)). Cancer incidence. Available from:
https://ganjoho.jp/en/professional/statistics/table_download.
html. Accessed October 31, 2020.
5. Lynge E, Rygaard C, Baillet MV, Dugué PA, Sander BB,
Bonde J and Rebolj M: Cervical cancer screening at crossroads.
APMIS 122: 667‑673, 2014.
6. National Comprehensive Cancer Network. Guidelines version
1.2021 for cervical cancer. Available from: https://www.nccn.
org/professionals/physician_gls/default.aspx. Accessed October
31, 2020.
7. Ebina Y, Mikami M, Nagase S, Tabata T, Kaneuchi M, Tashiro H,
Mandai M, Enomoto T, Kobayashi Y, Katabuchi H, et al:
Japan society of gynecologic oncology guidelines 2017 for the
treatment of uterine cervical cancer. Int J Clin Oncol 24: 1‑19,
2019.
8. Origoni M, Salvatore S, Perino A, Cucinella G and Candiani M:
Cervical intraepithelial neoplasia (CIN) in pregnancy: The state
of the art. Eur Rev Med Pharmacol Sci 18: 851‑860, 2014.
9. Sonoda K, Kobayashi H and Wake N: Cervical carcinoma
surveillance counterpoint. In: Patient Surveillance After Cancer
Treat ment. Joh nson F E, Maeha ra Y, Browma n GP,
Margenthaler JA, Audisio RA, Thompson JF, Johnson DY,
Earle CC and Virgo KS (eds). Springer Science Business Media,
New York, NY, pp335‑340, 2013.
10. Van Calsteren K, Vergote I and Amant F: Cervical neoplasia
during pregnancy: Diagnosis, management and prognosis. Best
Pract Res Clin Obstet Gynaecol 19: 611‑630, 2005.
11. Palle C, Bangsbøll S and Andreasson B: Cervical intraepithelial
neoplasia in pregnancy. Acta Obstet Gynecol Scand 79: 306‑310,
2000.
12. Smith LH, Dalrymple JL, Leiserowitz GS, Danielsen B and
Gilbert WM: Obstetrical deliveries associated with maternal
malignancy in California, 1992 through 1997. Am J Obstet
Gynecol 184: 1504‑1513, 2001.
13. Amant F, Berveiller P, Boere IA, Cardonick E, Fruscio R,
Fumagalli M, Halaska MJ, Hasenburg A, Johansson ALV,
Lambertini M, et al: Gynecologic cancers in pregnancy:
Guidelines based on a third international consensus meeting.
Ann Oncol 30: 1601‑1612, 2019.
14. Morice P, Uzan C, Gouy S, Verschraegen C and Haie‑Meder C:
Gynaecological cancers in pregnancy. Lancet 379: 558‑569, 2012.
15. Douligeris A, Prodromidou A, Psomiadou V, Iavazzo C and
Vorgias G: Abdominal radical trachelectomy during pregnancy:
A systematic review of the literature. J Gynecol Obstet Hum
Reprod 49: 101607, 2020.
16. Han SN, Kesic VI, Van Calsteren K, Petkovic S and Amant F;
ESGO ‘Cancer in Pregnancy’ Task Force: Cancer in pregnancy:
A survey of current clinical practice. Eur J Obstet Gynecol
Reprod Biol 167: 18‑23, 2013.
MOLECULAR AND CLINICAL ONCOLOGY 14: 67, 2021
17. Van Calsteren K, Heyns L, De Smet F, Van Eycken L, Gziri MM,
Van Gemert W, Halaska M, Vergote I, Ottevanger N and
Amant F: Cancer during pregnancy: An analysis of 215 patients
emphasizing the obstetrical and the neonatal outcomes. J Clin
Oncol 28: 683‑689, 2010.
18. Suzuki K, Furuhashi M, Kawamura T, Kubo M, Osato K and
Yamawaki T: Comparing papanicolaou test results obtained
during pregnancy and post‑partum. J Obstet Gynaecol Res 43:
705‑709, 2017.
19. Onuma K, Saad RS, Kanbour‑Shakir A, Kanbour AI and
Dabbs DJ: Clinical implications of the diagnosis ‘atypical
squamous cells, cannot exclude high‑grade squamous intraepi‑
thelial lesion’ in pregnant women. Cancer 108: 282‑287, 2006.
20. Trutnovsky G, Kolovetsiou‑Kreiner V and Reich O: p16/Ki‑67
dual‑stained cytology testing may predict postpartum outcome in
patients with abnormal papanicolaou cytology during pregnancy.
Acta Cytol 58: 293‑296, 2014.
21. Holt J, Stiltner L, Jamieson B and Fashner J: Clinical inquiries.
Should a nylon brush be used for Pap smears from pregnant
women? J Fam Pract 54: 463‑464, 2005.
22. Sood AK, Sorosky JI, Mayr N, Anderson B, Buller RE and
Niebyl J: Cervical cancer diagnosed shortly after pregnancy:
Prognostic variables and delivery routes. Obstet Gynecol 95:
832‑838, 2000.
23. Carocha AI, Pedroso C, Correia L, Gomes A and Jorge AF:
Glassy cell carcinoma of the cervix and metastasis in episiotomy
scar: A case report. J Low Genit Tract Dis 19: e31‑e34, 2015.
24. Nobbenhuis MA, Helmerhorst TJ, van den Brule AJ, Rozendaal L,
Bezemer PD, Voorhorst FJ and Meijer CJ: High‑risk human
papillomavirus clearance in pregnant women: Trends for lower
clearance during pregnancy with a catch‑up postpartum. Br J
Cancer 87: 75‑80, 2002.
25. Coppolillo EF, DE Ruda Vega HM, Brizuela J, Eliseth MC,
Barata A and Perazzi BE: High‑grade cervical neoplasia during
pregnancy: Diagnosis, management and postpartum findings.
Acta Obstet Gynecol Scand 92: 293‑297, 2013.
26. Frega A, Scirpa P, Corosu R, Verrico M, Scarciglia ML,
Primieri MR, Palazzo A, Iacovelli R and Moscarini M: Clinical
management and follow‑up of squamous intraepithelial cervical
lesions during pregnancy and postpartum. Anticancer Res 27:
2743‑2746, 2007.
This work is licensed under a Creative Commons
Attribution-NonCommercial-NoDerivatives 4.0
International (CC BY-NC-ND 4.0) License.
...
論文の公開元へ
